Table 3 of
Zhou, Mol Vis 2018; 24:560-573. Table 3 of
Zhou, Mol Vis 2018; 24:560-573.
Table 3. Comparisons of clinical data between probands and affected family members with mutations.
| NO. (%)† | |||
|---|---|---|---|
| Parameter | Probands | Family members | Comparison |
| n=12 | n=14 | ||
| Age (Y) | 8.91±4.03 | 37.00±11.18 | 1.80E-08 |
| eoHM‡ | 12 (100.0) | 11 (78.6) | 0.09 |
| Refractive error | -9.53±7.14 | -13.60±6.17 | 0.13 |
| Axial length | 27.72±1.88 | 26.35±2.40 | 0.12 |
| PVD/FH‡ | 9 (75.0) | 13 (92.9) | 0.21 |
| Vitreous opacity | 2 (16.7) | 7 (50.0) | 0.08 |
| Retinal abnormility | 0 (0.0) | 5 (35.7) | 0.02 |
| HJ‡ | 11 (91.7) | 3 (21.4) | 3.42E-04 |
| HJ (<16Y) | 11/11 (100.0) | 1/1 (100.0) | 1.00 |
| Other signs of STL diagnostic criteria | |||
| Orofacial abnormality | 10 (83.3) | 10 (71.4) | 0.47 |
| Musculoskeletal abnormality | 3 (25.0) | 8 (57.1) | 0.10 |
| Hearing loss | 5 (41.7)§ | 7 (50.0) | 0.67 |
| Diagnosis of STL after follow-up exam | 3 (25.0) | 7 (50.0) | 0.19 |
| Diagnosis of STL if new signs added‡ | 8 (66.7) | 13 (92.9) | 0.09 |